DE69332655T2 - Verfahren und testsatz für pyridinium-crosslink-assay - Google Patents

Verfahren und testsatz für pyridinium-crosslink-assay

Info

Publication number
DE69332655T2
DE69332655T2 DE69332655T DE69332655T DE69332655T2 DE 69332655 T2 DE69332655 T2 DE 69332655T2 DE 69332655 T DE69332655 T DE 69332655T DE 69332655 T DE69332655 T DE 69332655T DE 69332655 T2 DE69332655 T2 DE 69332655T2
Authority
DE
Germany
Prior art keywords
pyridinium
test set
immunocomplex
antibody
crosslinks
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69332655T
Other languages
English (en)
Other versions
DE69332655D1 (de
Inventor
J Cerelli
Y Daniloff
T Kung
F Zuk
Julia Ju
Jeffrey Evans
Pingren He
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Metra Biosystems Inc
Original Assignee
Metra Biosystems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metra Biosystems Inc filed Critical Metra Biosystems Inc
Application granted granted Critical
Publication of DE69332655D1 publication Critical patent/DE69332655D1/de
Publication of DE69332655T2 publication Critical patent/DE69332655T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69332655T 1992-07-31 1993-07-30 Verfahren und testsatz für pyridinium-crosslink-assay Expired - Fee Related DE69332655T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US92290692A 1992-07-31 1992-07-31
US99288892A 1992-12-17 1992-12-17
US3760293A 1993-03-26 1993-03-26
US3757193A 1993-03-26 1993-03-26
PCT/US1993/007203 WO1994003814A2 (en) 1992-07-31 1993-07-30 Method and kit for pyridinium crosslink assay

Publications (2)

Publication Number Publication Date
DE69332655D1 DE69332655D1 (de) 2003-02-27
DE69332655T2 true DE69332655T2 (de) 2003-11-27

Family

ID=27488453

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69332655T Expired - Fee Related DE69332655T2 (de) 1992-07-31 1993-07-30 Verfahren und testsatz für pyridinium-crosslink-assay

Country Status (8)

Country Link
EP (1) EP0653067B1 (de)
JP (2) JP3626182B2 (de)
AT (1) ATE231618T1 (de)
AU (1) AU684047B2 (de)
CA (1) CA2140921C (de)
DE (1) DE69332655T2 (de)
ES (1) ES2191015T3 (de)
WO (1) WO1994003814A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756361A (en) * 1992-12-17 1998-05-26 Metra Biosystems, Inc. Screening method for periodontal disease
US5661039A (en) * 1995-03-01 1997-08-26 Metra Biosystems, Inc. Perspiration assay for bone resorption
ES2214722T3 (es) * 1997-07-31 2004-09-16 Metra Biosystems, Inc. Metodo de ensayo de peptidos de colageno.
WO2001001136A1 (en) * 1999-06-30 2001-01-04 Quidel Corporation Method and kit for measuring total pyridinium crosslinks
US20060046273A1 (en) * 2004-08-27 2006-03-02 Lin-Zhi International Inc. Homogeneous enzyme immunoassay for oral fluid
CN105801688A (zh) * 2016-04-14 2016-07-27 苏州博源医疗科技有限公司 脱氧吡啶酚免疫原、抗体和检测试剂及制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4973666A (en) * 1987-11-06 1990-11-27 Washington Research Foundation Peptide fragments containing HP and LP cross-links
GB8815174D0 (en) * 1988-06-25 1988-08-03 Rowett Research Inst Method of monitoring collagen degradation

Also Published As

Publication number Publication date
EP0653067A1 (de) 1995-05-17
CA2140921A1 (en) 1994-02-01
AU4795593A (en) 1994-03-03
CA2140921C (en) 2003-09-30
JP3626182B2 (ja) 2005-03-02
ES2191015T3 (es) 2003-09-01
ATE231618T1 (de) 2003-02-15
EP0653067B1 (de) 2003-01-22
DE69332655D1 (de) 2003-02-27
WO1994003814A2 (en) 1994-02-17
AU684047B2 (en) 1997-12-04
WO1994003814A3 (en) 1994-04-14
JP2005010174A (ja) 2005-01-13
JPH07509780A (ja) 1995-10-26

Similar Documents

Publication Publication Date Title
DE3751432T2 (de) Rezeptoren für Immunkomplexe, Verfahren zur ihrer Herstellung und Verfahren zur Prüfung diese benutzend.
DE69733560D1 (de) TESTVERFAHREN UND REAGENZIEN ZUR QUANTIFIZIERUNG VON hBNP
NZ213959A (en) Immunoassay method for the determination of a particular protein analyte in a sample
DK104093D0 (da) Fremgangsmaade til bestemmelse af collagen-fragmenter i legemsvaesker, test-kit og midler til udoevelse af fremgangsmaaden og anvendelse af fremgangsmaaden til diagnosticering af lidelser associeret til collagen-metabolismen
KR930703611A (ko) 양막파열을 감지하는 진단방법과 이방법을 이용한 테스트키트
Hiramatsu et al. Development of a sensitive and accurate enzyme-linked immunosorbent assay (ELISA) system that can replace HPLC analysis for the determination of N 1, N 12-diacetylspermine in human urine
DE3800048A1 (de) Verfahren zur bestimmung eines antikoerpers in menschlichen koerperfluessigkeiten
DE69332655T2 (de) Verfahren und testsatz für pyridinium-crosslink-assay
DE3580563D1 (de) Nuklearbindungstest fuer steroidrezeptorsfunktion in krebsartigen zellen.
EP0787301B1 (de) Einschätzung der fragmentierungsmuster von kollagen in körperflüssigkeiten und diagnose von mit dem kollagenmetabolismus zusammenhängenden störungen
EP0125893A3 (de) Quantitative Bestimmung von Antigenen durch Enzym-Antikörper-Brückenverfahren
EP1059533A4 (de) Methode zum immunologischen nachweis des anti-hm1.24 antikörpers
EP0387027A3 (de) Methode und Reagenz zur Diagnose von Endometriose
ATE208040T1 (de) Immunoassay-reagenzien, testsätze und verfahren
Dusemund et al. Double-antibody enzyme-linked immunosorbent microassay for quantification of collagen types I and II
ATE286596T1 (de) Chemische modifikation von antikörpern und antigenen
DE10123929A1 (de) Verfahren zur Vorhersage eines Transplantatabstoßungsrisikos und immunologischer Testkit
Eisenbrey et al. Comparison of ultrasensitive methods for the measurement of IgE
ATE278193T1 (de) Verfahren zum testen eines asialoglycoproteinrezeptors und testreagenz dafür
Ho et al. A rapid method for quantitation of cell surface IgM by an enzyme-linked immunosorbent assay
DE59610394D1 (de) Antigenüberschussfreie nephelometrische und turbidimetrische Proteinbestimmungen
ES2029890T3 (es) Inmunoensayo.
Rugg et al. Radial partition immunoassay applied to automated quantification of human choriogonadotropin with use of two monoclonal antibodies.
Davidson et al. Lack of comparability between CEA analyses using three different methods
DE19980834T1 (de) Knorpel-Resorptionstests

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee